Recursion Pharmaceuticals Director Blake Borgeson Reports Sale of $155,200 in Common Shares

PUBT · 9h ago
Recursion Pharmaceuticals Director Blake Borgeson Reports Sale of $155,200 in Common Shares
  • Recursion Pharmaceuticals director Blake Borgeson sold 40,000 shares of Class A Common Stock on November 3, 2026.
  • The sale price was $3.88 per share, leaving Borgeson with direct ownership of 6,068,287 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001601830-26-000150), on November 04, 2026, and is solely responsible for the information contained therein.